REGN-EB3 and mAb114 reduced mortality in a clinical trial carried out during the ongoing outbreak in Democratic Republic of Congo.

Deaths attributed to the disease have outpaced those from Ebola this year.

The announcement comes as the country prepares for possible spread of the virus from Democratic Republic of Congo.

The cases, which spread from the outbreak in the DRC, include a five-year-old boy who died.

More than 1,100 people have died in the current Ebola outbreak in Democratic Republic of Congo that started in August 2018.

The person, whose identity has not been revealed, may have been exposed to the virus in Democratic Republic of Congo and is now at the University of Nebraska Medical Center.

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

As cases ramp up in Democratic Republic of Congo, the government has banned housing Ebola victims and promises police escorts for health workers at burials.

An accomplished infectious disease scientist, Meyers spent the 1960s treating and studying the condition in central Africa.